Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

NJ-HITEC Assists the First Eligible Provider Attest to Stage 2 Meaningful Use & Offers Remote Support Services
  • USA - English


News provided by

New Jersey Institute of Technology

May 14, 2014, 17:45 ET

Share this article

Share toX

Share this article

Share toX

Newark, NJ (PRWEB) May 14, 2014 -- The New Jersey Health Information Technology Extension Center (NJ-HITEC), one of the top-performing Regional Extension Centers (RECs) in the country, assisted Dr. Seema Rao attest to Stage 2 Meaningful Use. The internist from South Plainfield attested to Stage 2 in the earliest possible 90-day period for the federal Electronic Health Record (EHR) Incentive Program.

NJ-HITEC's Meaningful Use Director, Bala Thirumalainambi, explains, "Dr. Rao's efforts to achieve Stage 2 are remarkable, especially because she is a solo practitioner with limited resources. The fact that she had most of her patients on the patient portal from the day she started using her EHR system helped a great deal in achieving some of the more difficult measures. She was very engaged from the beginning and we are proud of the fact that she attested for the first 90 days for Stage 2 Meaningful Use."

Dr. Rao appreciated NJ-HITEC’s assistance, especially the guidance from the Meaningful Use team. “NJ-HITEC was instrumental in our success. Bala and his dedicated team were with us through every step. They supported us and answered our queries anytime of the day and even after-hours. NJ-HITEC personnel visited our office a number of times to clarify and work with us. This attestation would not have been possible without them. I strongly encourage all clinicians to engage NJ-HITEC in achieving Meaningful Use."

The term "Meaningful Use" probably means nothing to most patients but to doctors who are trying to move to the next level to improve the quality of care through technology, it is a key next step. Stage 2 requires physicians to provide a patient portal so individuals can access their health records electronically, can be sent reminders for medication refills or appointments, and can be more engaged in their healthcare management. In addition, Stage 2 requires doctors to meet Transition of Care measures that include greater efficiency in handling referrals and follow up testing and lab results.

Dr. Rao adds, “We wanted patients to take an active role and be a partner in their care. The patient portal helped us in achieving this goal. We encourage patients to get involved and understand their health metrics, diagnosis and steps taken to promote their health. The patient portal was integral to implementing this. I thank my patients for participation and becoming aware of the importance of their active role in care, health promotion and preventative measures. We discuss patient portal at every visit, help them to sign up and log on in the office to assist them to navigate the site, and if necessary on their smart phone.”            

NJ-HITEC is partnering with EHR vendors to help expedite the Stage 2 process for doctors. Its Meaningful Use team developed and offers a Gap Analysis Tool for Stage 2 that explains what information physicians need to collect and prepare to meet the criteria. Moreover, through its Member Portal, doctors can access of the latest information from the Centers for Medicare and Medicaid Services (CMS), educational materials, and webinars to help them through this process.

NJ-HITEC has assisted over 5,000 member physicians reach Stage 1 Meaningful Use that focused on data collection. In Stage 2, doctors are required to use the data they collect to better manage patient care. Because of the process that NJ-HITEC developed to assist doctors, the team is able to offer its services remotely as well.

If you are an Eligible Provider or hospital interested in NJ-HITEC's Stage 2 Consulting Services, visit http://www.njhitec.org/contact-us/contact-us-form/?utm_source=iContact&utm_medium=email&utm_campaign=Media&utm_content=NJ-HITEC+Assists+the+First+NJ+Stage+2+Provider or call 973-642-4055.

Media Contact: Denise Anderson, Ph.D., denisea(at)njit(dot)edu or 973-596-3434.

About NJ-HITEC
NJ-HITEC is a national leader as one of 62 federally designated Regional Extension Centers nationwide established to improve American healthcare delivery and patient care through the investment in Health Information Technology (Health IT). NJ-HITEC provides support and assistance to New Jersey’s physicians in the selection, implementation, and achievement of “Meaningful Use” of an ONC accredited Electronic Health Record (EHR) system. NJ-HITEC is a thought leader in Health IT with over 8,000 members and close to 5,000 Stage 1 Meaningful Users. Moreover, it is now preparing its members as well as physicians from other states for Stage 2 Meaningful Use that began in January 2014. NJ-HITEC was established in June 2010 by New Jersey Institute of Technology (NJIT) through a $23 million grant from the U.S. Department of Health and Human Services, Office of the National Coordinator as part of the 2009 American Reinvestment and Recovery Act (2009 ARRA).
Visit http://www.njhitec.org for more information.

Tanya Klein, New Jersey Institute of Technology, +1 973 596-3433, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.